324 related articles for article (PubMed ID: 17200715)
1. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.
MacArthur JM; Bishop JR; Stanford KI; Wang L; Bensadoun A; Witztum JL; Esko JD
J Clin Invest; 2007 Jan; 117(1):153-64. PubMed ID: 17200715
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism.
Bishop JR; Stanford KI; Esko JD
Curr Opin Lipidol; 2008 Jun; 19(3):307-13. PubMed ID: 18460924
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate 2-O-sulfotransferase is required for triglyceride-rich lipoprotein clearance.
Stanford KI; Wang L; Castagnola J; Song D; Bishop JR; Brown JR; Lawrence R; Bai X; Habuchi H; Tanaka M; Cardoso WV; Kimata K; Esko JD
J Biol Chem; 2010 Jan; 285(1):286-94. PubMed ID: 19889634
[TBL] [Abstract][Full Text] [Related]
4. Hepatic heparan sulfate proteoglycans and endocytic clearance of triglyceride-rich lipoproteins.
Foley EM; Esko JD
Prog Mol Biol Transl Sci; 2010; 93():213-33. PubMed ID: 20807647
[TBL] [Abstract][Full Text] [Related]
5. Hepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in mice.
Foley EM; Gordts PLSM; Stanford KI; Gonzales JC; Lawrence R; Stoddard N; Esko JD
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2065-74. PubMed ID: 23846497
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.
Stanford KI; Bishop JR; Foley EM; Gonzales JC; Niesman IR; Witztum JL; Esko JD
J Clin Invest; 2009 Nov; 119(11):3236-45. PubMed ID: 19805913
[TBL] [Abstract][Full Text] [Related]
7. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
[TBL] [Abstract][Full Text] [Related]
8. Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing.
Mahley RW; Huang Y
J Clin Invest; 2007 Jan; 117(1):94-8. PubMed ID: 17200713
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations.
Al-Haideri M; Goldberg IJ; Galeano NF; Gleeson A; Vogel T; Gorecki M; Sturley SL; Deckelbaum RJ
Biochemistry; 1997 Oct; 36(42):12766-72. PubMed ID: 9335533
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
[TBL] [Abstract][Full Text] [Related]
11. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
Ji ZS; Sanan DA; Mahley RW
J Lipid Res; 1995 Mar; 36(3):583-92. PubMed ID: 7539827
[TBL] [Abstract][Full Text] [Related]
12. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
Zheng C; Khoo C; Furtado J; Sacks FM
Circulation; 2010 Apr; 121(15):1722-34. PubMed ID: 20368524
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
Williams KJ; Fless GM; Petrie KA; Snyder ML; Brocia RW; Swenson TL
J Biol Chem; 1992 Jul; 267(19):13284-92. PubMed ID: 1320015
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway.
Fernández-Borja M; Bellido D; Vilella E; Olivecrona G; Vilaró S
J Lipid Res; 1996 Mar; 37(3):464-81. PubMed ID: 8728311
[TBL] [Abstract][Full Text] [Related]
16. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E.
Mahley RW; Ji ZS
J Lipid Res; 1999 Jan; 40(1):1-16. PubMed ID: 9869645
[TBL] [Abstract][Full Text] [Related]
17. The uptake of lipoprotein-borne phylloquinone (vitamin K1) by osteoblasts and osteoblast-like cells: role of heparan sulfate proteoglycans and apolipoprotein E.
Newman P; Bonello F; Wierzbicki AS; Lumb P; Savidge GF; Shearer MJ
J Bone Miner Res; 2002 Mar; 17(3):426-33. PubMed ID: 11874234
[TBL] [Abstract][Full Text] [Related]
18. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
Ji ZS; Fazio S; Mahley RW
J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
[TBL] [Abstract][Full Text] [Related]
19. Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants.
Anower-E-Khuda F; Singh G; Deng Y; Gordts PLSM; Esko JD
Glycobiology; 2019 Jul; 29(8):582-592. PubMed ID: 31094413
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
Dergunov AD
Biochemistry (Mosc); 2004 Jul; 69(7):720-37. PubMed ID: 15310270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
